"Our next step will be the setup of our testing lab and related infrastructure in Monterrey, and I will personally oversee these efforts," Milici said. "The LIPOSTIM clinical trial is scheduled to begin soon thereafter."

Milici added that GeneThera is working to secure additional capital required to advance its current programs, and has been in discussions with the funding arm of the New Jersey-based Pharma Finance Conference, which was recently attended by GeneThera.

Leonardo Zangani, president of New Jersey based Zangani Investment Community and organizer of Pharma Finance Conference series, stated, "As it happens in every edition of Pharma Finance, we can see positive results both at the scientific and financial levels. The agreement between GeneThera, UNIROMA2 and UCSC is an example of this success."

It seems like they have a real plan with specific milestones in place! I see that their IR has now put them on their website as a client, which I believe adds alot of credibility to a company of this size and hopefully Institutions and Mutual Funds will take notice when in my opinion the price goes up significantly...Justthefacts

PS: link to IR: http://www.pfeifferhigh.com/The%20firm/o...